Gujarat Themis Biosyn Limited (GUJTHEM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE942C01045
Key metrics
- Market Cap
- ₹4,161 Cr
- P/E Ratio
- 85.47
- EPS
- 4.46
- Book Value
- 26.41
- P/B Ratio
- 13.98
- ROE
- 16.22%
- ROCE
- 13.93%
- Debt / Equity
- 0.56
- Net Margin
- 28.15%
- Revenue Growth
- 9.96%
- Profit Growth
- -4.28%
- Dividend Yield
- 0.18%
- 52W High
- ₹479.00
- 52W Low
- ₹225.05
- Market Cap Band
- small cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 71.98%
The full Gujarat Themis Biosyn Limited analysis
Create a free account to open the complete GUJTHEM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.